Preventing Collateral Damage in Crohn's Disease: The L,mann Index
2016-01-01 Fiorino, G; Bonifacio, C; Peyrin-Biroulet, L; Danese, S
Targeting the gut layers in Crohn's disease: mucosal or transmural healing?
2020-01-01 Zacharopoulou, Eirini; Craviotto, Vincenzo; Fiorino, Gionata; Furfaro, Federica; Zilli, Alessandra; Gilardi, Daniela; Peyrin-Biroulet, Laurent; Danese, Silvio; Allocca, Mariangela
Ustekinumab for treating ulcerative colitis: an expert opinion
2020-01-01 Biancone, Livia; Ardizzone, Sandro; Armuzzi, Alessandro; Castiglione, Fabiana; D'Incà, Renata; Danese, Silvio; Daperno, Marco; Gionchetti, Paolo; Rizzello, Fernando; Scribano, Maria Lia; Vecchi, Maurizio; Orlando, Ambrogio
Influence of Helicobacter pylori infection on metalloproteinases expression in gastric mucosa
2002-01-01 Papa, A; Danese, S; Ricci, R; Covino, M; Maggiano, N; Rinelli, A; Grillo, A; Piscaglia, A; Vecchio, F; Gasbarrini, G; Gasbarrini, A
Familial aggregation in inflammatory bowel disease: Is it genes or environment?
2011-01-01 Nunes, T; Fiorino, G; Danese, S; Sans, M
IBD IN 2013 Enriching the therapeutic armamentarium for IBD
2014-01-01 Danese, S; Peyrin-Biroulet, L
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6
2010-01-01 Vetrano, S.; Borroni, E. M.; Sarukhan, A.; Savino, B.; Bonecchi, R.; Correale, C.; Arena, V.; Fantini, M.; Roncalli, M.; Malesci, A.; Mantovani, A.; Locati, M.; Danese, S.
Adalimumab in active ulcerative colitis: A "real-life" observational study
2013-01-01 Armuzzi, A; Biancone, L; Daperno, M; Coli, A; Pugliese, D; Annese, V; Aratari, A; Ardizzone, S; Balestrieri, P; Bossa, F; Cappello, M; Castiglione, F; Cicala, M; Danese, S; D'Inca, R; Dulbecco, P; Feliciangeli, G; Fries, W; Genise, S; Gionchetti, P; Gozzi, S; Kohn, A; Lorenzetti, R; Milla, M; Onali, S; Orlando, A; Papparella, Lg; Renna, S; Ricci, C; Rizzello, F; Sostegni, R; Guidi, L; Papi, C
Tolerogenic dendritic cells: cytokine modulation comes of age
2006-01-01 Rutella, S; Danese, S; Leone, G
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease
2010-01-01 Fiorino, G.; Correale, C.; Fries, W.; Repici, A.; Malesci, A.; Danese, S.
VEGF in inflammatory bowel disease: A master regulator of mucosal immune-driven angiogenesis
2008-01-01 Danese, S
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease
2015-01-01 Fiorino, G.; Bonifacio, C.; Allocca, M.; Repici, A.; Balzarini, L.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S.
Evolving therapeutic goals in ulcerative colitis: towards disease clearance
2020-01-01 Danese, S; Roda, G; Peyrin-Biroulet, L
Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis
2017-01-01 Van Welden, S; De Vos, M; Wielockx, B; Tavernier, Sj; Dullaers, M; Neyt, S; Descamps, B; Devisscher, L; Devriese, S; Van Den Bossche, L; Holvoet, T; Baeyens, A; Correale, C; D'Alessio, S; Vanhove, C; De Vos, F; Verhasselt, B; Breier, G; Lambrecht, Bn; Janssens, S; Carmeliet, P; Danese, S; Elewaut, D; Laukens, D; Hindryckx, P
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer
2019-01-01 Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico
Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
2019-01-01 Lovisa, S; Genovese, G; Danese, S
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
2015-01-01 Peyrin-Biroulet, L; Sandborn, W; Sands, Be; Reinisch, W; Bemelman, W; Bryant, Rv; D'Haens, G; Dotan, I; Dubinsky, M; Feagan, B; Fiorino, G; Gearry, R; Krishnareddy, S; Lakatos, Pl; Loftus, Ev; Marteau, P; Munkholm, P; Murdoch, Tb; Ordas, I; Panaccione, R; Riddell, Rh; Ruel, J; Rubin, Dt; Samaan, M; Siegel, Ca; Silverberg, Ms; Stoker, J; Schreiber, S; Travis, S; Van Assche, G; Danese, S; Panes, J; Bouguen, G; O'Donnell, S; Pariente, B; Winer, S; Hanauer, S; Colombel, Jf
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients
2017-01-01 Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S
Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile
2019-01-01 Argollo, M; Kotze, Pg; Lamonaca, L; Gilardi, D; Furfaro, F; Yamamoto, T; Danese, S
Dose Optimization Is Effective in Patients With Ulcerative Colitis Losing Response to Infliximab: A Collaborative Multicentre Retrospective Study
2013-01-01 Cesarini, M; Katsanos, K; Ellul, P; Lakatos, Pl; Papamichael, K; Caprioli, F; Tsianos, Ev; Mantzaris, Gj; Danese, S; Fiorino, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Preventing Collateral Damage in Crohn's Disease: The L,mann Index | 1-gen-2016 | Fiorino, G; Bonifacio, C; Peyrin-Biroulet, L; Danese, S | |
| Targeting the gut layers in Crohn's disease: mucosal or transmural healing? | 1-gen-2020 | Zacharopoulou, Eirini; Craviotto, Vincenzo; Fiorino, Gionata; Furfaro, Federica; Zilli, Alessandra; Gilardi, Daniela; Peyrin-Biroulet, Laurent; Danese, Silvio; Allocca, Mariangela | |
| Ustekinumab for treating ulcerative colitis: an expert opinion | 1-gen-2020 | Biancone, Livia; Ardizzone, Sandro; Armuzzi, Alessandro; Castiglione, Fabiana; D'Incà, Renata; Danese, Silvio; Daperno, Marco; Gionchetti, Paolo; Rizzello, Fernando; Scribano, Maria Lia; Vecchi, Maurizio; Orlando, Ambrogio | |
| Influence of Helicobacter pylori infection on metalloproteinases expression in gastric mucosa | 1-gen-2002 | Papa, A; Danese, S; Ricci, R; Covino, M; Maggiano, N; Rinelli, A; Grillo, A; Piscaglia, A; Vecchio, F; Gasbarrini, G; Gasbarrini, A | |
| Familial aggregation in inflammatory bowel disease: Is it genes or environment? | 1-gen-2011 | Nunes, T; Fiorino, G; Danese, S; Sans, M | |
| IBD IN 2013 Enriching the therapeutic armamentarium for IBD | 1-gen-2014 | Danese, S; Peyrin-Biroulet, L | |
| The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 | 1-gen-2010 | Vetrano, S.; Borroni, E. M.; Sarukhan, A.; Savino, B.; Bonecchi, R.; Correale, C.; Arena, V.; Fantini, M.; Roncalli, M.; Malesci, A.; Mantovani, A.; Locati, M.; Danese, S. | |
| Adalimumab in active ulcerative colitis: A "real-life" observational study | 1-gen-2013 | Armuzzi, A; Biancone, L; Daperno, M; Coli, A; Pugliese, D; Annese, V; Aratari, A; Ardizzone, S; Balestrieri, P; Bossa, F; Cappello, M; Castiglione, F; Cicala, M; Danese, S; D'Inca, R; Dulbecco, P; Feliciangeli, G; Fries, W; Genise, S; Gionchetti, P; Gozzi, S; Kohn, A; Lorenzetti, R; Milla, M; Onali, S; Orlando, A; Papparella, Lg; Renna, S; Ricci, C; Rizzello, F; Sostegni, R; Guidi, L; Papi, C | |
| Tolerogenic dendritic cells: cytokine modulation comes of age | 1-gen-2006 | Rutella, S; Danese, S; Leone, G | |
| Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease | 1-gen-2010 | Fiorino, G.; Correale, C.; Fries, W.; Repici, A.; Malesci, A.; Danese, S. | |
| VEGF in inflammatory bowel disease: A master regulator of mucosal immune-driven angiogenesis | 1-gen-2008 | Danese, S | |
| Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease | 1-gen-2015 | Fiorino, G.; Bonifacio, C.; Allocca, M.; Repici, A.; Balzarini, L.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S. | |
| Evolving therapeutic goals in ulcerative colitis: towards disease clearance | 1-gen-2020 | Danese, S; Roda, G; Peyrin-Biroulet, L | |
| Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis | 1-gen-2017 | Van Welden, S; De Vos, M; Wielockx, B; Tavernier, Sj; Dullaers, M; Neyt, S; Descamps, B; Devisscher, L; Devriese, S; Van Den Bossche, L; Holvoet, T; Baeyens, A; Correale, C; D'Alessio, S; Vanhove, C; De Vos, F; Verhasselt, B; Breier, G; Lambrecht, Bn; Janssens, S; Carmeliet, P; Danese, S; Elewaut, D; Laukens, D; Hindryckx, P | |
| NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer | 1-gen-2019 | Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico | |
| Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease | 1-gen-2019 | Lovisa, S; Genovese, G; Danese, S | |
| Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target | 1-gen-2015 | Peyrin-Biroulet, L; Sandborn, W; Sands, Be; Reinisch, W; Bemelman, W; Bryant, Rv; D'Haens, G; Dotan, I; Dubinsky, M; Feagan, B; Fiorino, G; Gearry, R; Krishnareddy, S; Lakatos, Pl; Loftus, Ev; Marteau, P; Munkholm, P; Murdoch, Tb; Ordas, I; Panaccione, R; Riddell, Rh; Ruel, J; Rubin, Dt; Samaan, M; Siegel, Ca; Silverberg, Ms; Stoker, J; Schreiber, S; Travis, S; Van Assche, G; Danese, S; Panes, J; Bouguen, G; O'Donnell, S; Pariente, B; Winer, S; Hanauer, S; Colombel, Jf | |
| Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients | 1-gen-2017 | Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S | |
| Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile | 1-gen-2019 | Argollo, M; Kotze, Pg; Lamonaca, L; Gilardi, D; Furfaro, F; Yamamoto, T; Danese, S | |
| Dose Optimization Is Effective in Patients With Ulcerative Colitis Losing Response to Infliximab: A Collaborative Multicentre Retrospective Study | 1-gen-2013 | Cesarini, M; Katsanos, K; Ellul, P; Lakatos, Pl; Papamichael, K; Caprioli, F; Tsianos, Ev; Mantzaris, Gj; Danese, S; Fiorino, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40134
Data di pubblicazione
- In corso di stampa9
- 2020 - 202712186
- 2010 - 201915980
- 2000 - 20097460
- 1990 - 19993486
- 1980 - 1989935
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.823
- Elsevier B.V.809
- Springer Science and Business Med...552
- John Wiley and Sons Inc549
- Oxford University Press506
- Lippincott Williams and Wilkins435
- Springer374
- Elsevier Ltd350
- MDPI348
- Springer Nature296
Rivista
- EUROPEAN UROLOGY535
- BLOOD372
- PLOS ONE313
- JOURNAL OF NEUROLOGY291
- EUROPEAN JOURNAL OF HEART FAILURE281
- NEUROLOGY270
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL225
- MULTIPLE SCLEROSIS219
- SCIENTIFIC REPORTS215
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19636
- Retrospective Studies628
- Treatment Outcome603
- Prognosis483
Lingua
- eng29490
- ita1971
- fre65
- und55
- spa34
- ger26
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext32003
- reserved4297
- open3722
- partially open104
- embargoed7
- mixed1